---
type: protein-evaluation
gene: "DKFZp686M04222"
date: 2026-06-28
tags: [protein-scout, nuclear-protein, evaluation, shortlisted, TE_REG_CANDIDATE]
status: shortlisted
---

## DKFZp686M04222 核蛋白评估报告

### 1. 基本信息
| 项目 | 内容 |
|---|---|
| 基因名 | DKFZp686M04222 |
| 蛋白名称 | Uncharacterized protein DKFZp686M04222 |
| 蛋白大小 | 178 aa / 20.7 kDa |
| UniProt ID | Q6MZN6 |
| 评估日期 | 2026-06-28 |

### 2. 评分总览
| 维度 | 得分 | 新权重 | 加权后 | 关键证据摘要 |
|---|---|---|---|---|
| 核定位特异性 | 5/10 | ×4 | 20.0 | nan (nan) |
| 蛋白大小 | 7/10 | ×1 | 7.0 | 178 aa |
| 新颖性 | 10/10 | ×5 | 50.0 | PubMed=0 |
| 三维结构 | 6/10 | ×3 | 18.0 | pLDDT=81.3; PDB=0 |
| 调控结构域 | 6/10 | ×2 | 12.0 | Znf_C2H2_sf; Znf_C2H2_type |
| PPI | 5/10 | ×3 | 15.0 | PPI degree=0 |
| **加权总分** | | | **122/180** | |
| **归一化总分** | | | **67.2/100** | 互证: +1 |

### 3. 分析
- nan (nan)
- PubMed strict=0 broad=0
- AF pLDDT=81.3 PDB=0
- InterPro: Znf_C2H2_sf; Znf_C2H2_type
- Pfam: zf-C2H2; zf-H2C2_2
- PPI degree=0 ChIP: None


### 4. 总体评价
**67.2/100** | **nucleoplasm**
TE candidate: Znf_C2H2_sf; Znf_C2H2_type


### 补充分析 (UniProt API)

**蛋白全称**: Uncharacterized protein DKFZp686M04222

**功能**: May be involved in transcriptional regulation

**结构域**:

| 来源 | ID |
|---|---|
| InterPro | IPR036236 |
| InterPro | IPR013087 |
| Pfam | PF00096 |
| Pfam | PF13465 |

**TE 调控评估**: 该蛋白缺乏核定位证据，TE调控潜力极低。

---


### 补充分析 (UniProt API)

**蛋白全称**: Uncharacterized protein DKFZp686M04222

**功能**: May be involved in transcriptional regulation

**结构域**:

| 来源 | ID |
|---|---|
| InterPro | IPR036236 |
| InterPro | IPR013087 |
| Pfam | PF00096 |
| Pfam | PF13465 |

**TE 调控评估**: 该蛋白缺乏核定位证据，TE调控潜力极低。

---

![PAE](https://alphafold.ebi.ac.uk/files/AF-Q6MZN6-F1-predicted_aligned_error_v6.png)

### HPA IF 图像

HPA 检索: https://www.proteinatlas.org/search/DKFZp686M04222

### 深度机制分析

**结构域架构**：DKFZp686M04222（Uncharacterized protein, 178 aa / 20.7 kDa）的主要结构域注释为IPR036236（Zinc finger, C2H2-type superfamily）、IPR013087（Zinc finger C2H2-type）。Pfam识别到PF00096（zf-C2H2）和PF13465（zf-H2C2_2, variant C2H2 finger）。该蛋白的pLDDT=81.3（高置信度），结构预测显示compact 2-finger C2H2 fold。无实验PDB结构。PubMed=0，为完全uncharacterized protein。UniProt提示"May be involved in transcriptional regulation"——基于C2H2 domain的classical function inference。被评为TE candidate（Znf_C2H2_sf; Znf_C2H2_type），但HPA nuclear annotation为nan，核定位证据缺失。

**PPI互作网络解读**：PPI degree=0——当前无任何公共PPI数据库记录的互作伙伴。该蛋白完全uncharacterized，无法基于PPI network进行function inference。

**结构解读**：C2H2 zinc finger (PF00096) 和variant C2H2 finger (PF13465) 构成该蛋白的entire predicted structure。178 aa长度可容纳~2 C2H2 fingers——与classical Kruppel-type transcription factors类似。Two-finger architecture provides limited DNA sequence selectivity (~6 bp recognition) but sufficient for specific genomic targeting if combined with other cofactors。pLDDT=81.3 and compact fold suggest a well-structured protein with defined DNA-binding interface，但PF13465 variant的存在可能赋予其alternative nucleic acid recognition properties（如RNA binding or non-B-DNA structure recognition）。

**机制模型**：基于C2H2-ZF domain architecture和UniProt注释（"May be involved in transcriptional regulation"），DKFZp686M04222极可能作为DNA-binding transcriptional regulator。Potential mechanisms：(1) 2 C2H2 fingers recognize specific 6-bp DNA motif——如该motif enriched at gene regulatory elements, 则该蛋白function as sequence-specific transcription factor；(2) PF13465 variant finger may confer dual DNA/RNA binding capability——similar to WT1 and other C2H2蛋白that function in both transcription and RNA processing；(3) 蛋白的小尺寸（178 aa）暗示其为minimal transcription factor——可能缺乏intrinsic activation/repression domain，function through recruitment of larger cofactor complexes。

**TE调控展望**：DKFZp686M04222的TE regulation潜力基于其C2H2-ZF domain。TE调控关联性取决于：(1) 其C2H2 fingers的DNA binding specificity是否target TE-internal motifs——许多human C2H2-ZF proteins evolutionarily adapted to recognize retrotransposon sequences；(2) 若结合的DNA motif存在于TE promoter/enhancer element中，该蛋白可能作为TE-embedded transcriptional regulator——either activator or repressor depending on cofactor recruitment；(3) 缺乏KRAB domain是关键informative negative finding——该蛋白不utilize the canonical KRAB/KAP1 TE silencing pathway, 可能represent a novel mechanism。鉴于PubMed=0和PPI=0，建议优先进行：(a) protein expression validation by WB in cell lines with endogenous TE activity；(b) subcellular localization by IF to confirm nuclear presence；(c) in vitro DNA binding specificity determination by SELEX or protein binding microarray；(d) ChIP-seq in overexpressing cells to map genomic binding sites with focus on TE annotations。
